(Q35048069)

6 August 2017

1 reference

title

Antipsychotics and QT prolongation (English)

1 reference

6 August 2017

Taylor DM

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Acta Psychiatrica Scandinavica

6 August 2017

published in

1 reference

6 August 2017

volume

107

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

85-95

1 reference

T cell receptor usage in autoimmune disease

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Drug-induced QT prolongation in women during the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Long QT syndromes and torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Measurement of the QT interval and the risk associated with QTc interval prolongation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Influence of lead selection and population on automated measurement of QT dispersion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Time dependent variability of QT dispersion after acute myocardial infarction and its relation to ventricular fibrillation: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Electrophysiological basis of QT dispersion measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Sudden unexplained death in psychiatric in-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Antipsychotics and the risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

The effect of thioridazine hydrochloride and chlorpromazine on the electrocardiogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Iatrogenic torsade de pointes induced by thioridazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

A fatality during haloperidol treatment: mechanism of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Sudden death in patients receiving clozapine treatment: a preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Review article: cardiac adverse effects of gastrointestinal prokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Clozapine and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

More on potassium, the heart, and antipsychotic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

QT dispersion and sudden unexpected death in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

The QT interval and torsade de pointes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Is QT interval prolongation harmful? A regulatory perspective

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

QT interval prolongation predicts cardiovascular mortality in an apparently healthy population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

1 reference

7 January 2021

Risk of sudden death on high-dose antipsychotic medication: QTc dispersion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

QT dispersion: an electrocardiographic derivative of QT prolongation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

The value of QTc dispersion in assessment of cardiac risk in elective aortic aneurysm surgery

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Post-mortem antipsychotic drug concentrations and unexplained deaths

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Chlorpromazine therapy, and associated acute disturbances of cardiac rhythm

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Death Associated With Ventricular Arrhythmia and Thioridazine Hydrochloride

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

High- and Low-Potency Neuroleptics in Elderly Psychiatric Patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Haloperidol-induced torsades de pointes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol Overdose

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Sudden death in a patient taking haloperidol

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Haloperidol-induced torsade de pointes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Prolonged QT interval in acute psychotic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Droperidol causes a dose-dependent prolongation of the QT interval

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Electrocardiographic changes in patients receiving neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Sudden death and flupenthixol decanoate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Electrocardiographic abnormalities in patients treated with clozapine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Clozapine induced atrial fibrillation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Delusion of pregnancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Fatal Cardiac Event following Initiation of Risperidone Therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

1 reference

7 January 2021

Prolongation of QT interval in isolated feline hearts by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

The QT interval and the atypical antipsychotic, sertindole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

A review of the safety and tolerability of sertindole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Intoxication with olanzapine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Safety of amisulpride (Solian): a review of 11 clinical studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Overdose of Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Overdose profiles of new antipsychotic agents

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

QT interval prolongation associated with quetiapine (Seroquel) overdose

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Safety in overdose of quetiapine: a case report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

1 reference

7 January 2021

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

1 reference

7 January 2021

The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

The heart of psychotropic drug therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Potassium, antipsychotic agents, arrhythmias, and sudden death

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Psychotropic drugs, HERG, and the heart

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Drug-induced torsade de pointes. Incidence, management and prevention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

Pharmacokinetic interactions involving clozapine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02078.X

7 January 2021

10.1034/J.1600-0447.2003.02078.X

Identifiers

DOI

1 reference

6 August 2017

1 reference